Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion type Assertion NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_head.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion description "[Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_provenance.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion evidence source_evidence_literature NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_provenance.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion SIO_000772 9192768 NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_provenance.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion wasDerivedFrom befree-20140225 NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_provenance.
- NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_assertion wasGeneratedBy ECO_0000203 NP363545.RAZN7wopvzIyYswbWAKDCCj4diZxhxNC7man40VDm86T0130_provenance.